Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver
Authors:
Open Access
- 6 June 2013
- journal article
- research article
- Published by Hindawi Limited in Advances in Virology
- Vol. 2013, 1-5
Abstract
Introduction. Patients with chronic liver disease (CLD) are more likely to have severe morbidity and fatality rate due to superimposed acute or chronic hepatitis B (HBV) infection. The literature has shown that hepatitis B vaccines are safe and effective in patients with CLD, but the data in cirrhosis liver is lacking. We assessed the safety and immunogenicity of HBV vaccine in patients with cirrhosis liver. Methods. CTP classes A and B CLD patients negative for hepatitis B surface antigen and antibody to hepatitis B core antigen were included. All patients received three doses of hepatitis B vaccine 20mcg intramuscularly at 0, 30, and 60 days. Anti-HBs antibody was measured after 120 days. Results. 52 patients with mean age years were studied. Response rates in CTP classes A and B were 88% and 33.3%. We observed that the alcoholic chronic liver disease had less antibody response (44%) than other causes of chronic liver disease such as cryptogenic 69% and HCV 75%. Conclusions. Patients with cirrhosis liver will have low antibody hepatitis B titers compared to general population. As the age and liver disease progress, the response rate for hepatitis B vaccination will still remain to be weaker.Keywords
This publication has 20 references indexed in Scilit:
- National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data.2004
- Hepatitis vaccination in patients with chronic liver diseaseAlimentary Pharmacology & Therapeutics, 2004
- Deaths: final data for 2001.2003
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—June 10-12, 2002Hepatology, 2002
- Chronic Hepatitis BNew England Journal of Medicine, 2002
- Risks Associated With Hepatitis A and Hepatitis B in Patients With Hepatitis CJournal of Clinical Gastroenterology, 2001
- Double-dose accelerated hepatitis B vaccine in patients with end-stage liver diseaseLiver Transplantation, 2001
- Hepatitis B virus vaccine for patients with hepatitis C virus infection.Infection, 2000
- Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting listLiver Transplantation, 2000
- Efficacy of a High and Accelerated Dose of Hepatitis B Vaccine in Alcoholic PatientsThe American Journal of Medicine, 1997